Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology

NCT: NCT06380361 · COMPLETED

NCT IDNCT06380361
StatusCOMPLETED
Start Date2024-03-28
Completion2025-04-23

Brief Summary

The objective of the study is to evaluate the feasibility of the BioSpy System sensor to differentiate tissues that are encountered during bronchoscopic biopsy of endobronchial tumors and peripheral lung nodules and masses.

Frequently Asked Questions

What is InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology?

InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology is a clinical trial registered under NCT06380361. Current status: COMPLETED.

What is the status of NCT06380361?

The current status of NCT06380361 (InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology) is: COMPLETED.

When did InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology start?

InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology started on 2024-03-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑